HB 1466 (2022)
Protect prescriptions for off-label use
Summary:
Allows a physician, physician assistant, and advanced practice registered nurse (APRN) to prescribe an FDA approved drug for an off-label indication (e.g. prescribing ivermectin for COVID-19). The bill also prohibits disciplinary action against a pharmacist for filling a valid prescription for off-label use.
A conference committee of representatives and senators amended the bill to require informed consent from the patient in some circumstances before providing an off-label prescription.
Bill Became Law?:
Yes
Status:
Status Detail:
Signed by Governor
Public Hearing Date:
04/06/2022 10:00 am
Public Hearing Location:
SH Room 100
House Voting Date:
03/10/2022
Senate Voting Date:
05/26/2022
